Noven Pharmaceuticals

Noven Pharmaceuticals (United States) is linked to 1 FDA-registered manufacturing site. 50 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Noven Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/noven-pharmaceuticals

Overview

Noven Pharmaceuticals is a pharmaceutical company headquartered in Miami, United States.

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Noven Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

50 FDA enforcement records linked to this company.

  • 4832026-08-24

    Identity Testing of Each Component

  • 4832026-08-24

    Backup file not maintained

  • 4832026-08-24

    Second person sign off

  • 4832026-08-24

    input/output verification

  • recall — Class II2024-11-27

    Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

  • recall — Class II2023-03-29

    Defective Delivery System: Out of specification for shear.

  • recall — Class II2023-03-29

    Defective Delivery System: Out of specification for shear.

  • recall — Class II2023-03-29

    Defective Delivery System: Out of specification for shear.

  • recall — Class II2023-03-29

    Defective Delivery System: Out of specification for shear.

  • recall — Class II2022-12-07

    Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

  • recall — Class II2022-07-06

    Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

  • recall — Class II2022-06-01

    Defective Delivery System: customer complaints exceeded respective action limits.

  • recall — Class II2021-08-25

    Failed Stability Specifications; out of specification for shear.

  • recall — Class II2021-08-25

    Failed Stability Specifications; out of specification for shear.

  • recall — Class II2021-06-02

    Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

  • recall — Class II2021-06-02

    Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

  • recall — Class II2021-04-28

    Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

  • recall — Class II2021-04-28

    Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

  • recall — Class II2021-03-10

    Defective Delivery System: Out of specification for mechanical peel.

  • recall — Class II2021-03-10

    Defective Delivery System: Out of specification for mechanical peel.

  • recall — Class II2021-03-10

    Defective Delivery System: Out of specification for mechanical peel.

  • recall — Class II2021-03-10

    Defective Delivery System: Out of specification for mechanical peel.

  • recall — Class II2018-10-03

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

  • recall — Class II2018-10-03

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

  • recall — Class II2018-10-03

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

  • recall — Class II2018-10-03

    Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

  • recall — Class II2018-05-16

    Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

  • recall — Class II2018-05-16

    Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

  • recall — Class II2018-04-25

    Defective Delivery System: Out of specification for adhesive transfer.

  • recall — Class II2017-09-27

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

  • recall — Class II2017-09-27

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

  • recall — Class II2017-09-27

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

  • recall — Class II2017-09-27

    Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

  • recall — Class III2017-07-05

    Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

  • recall — Class II2017-01-18

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

  • recall — Class II2017-01-18

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

  • recall — Class II2017-01-18

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

  • warning_letter2016-08-05

    FDA Warning Letter (drug product)

  • recall — Class II2016-07-20

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

  • recall — Class II2016-07-20

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

  • recall — Class II2016-07-20

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

  • recall — Class II2015-10-14

    Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.

  • recall — Class II2015-06-03

    Defective Delivery System: One lot exceeded the mechanical peel specification

  • recall — Class II2015-04-22

    Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

  • recall — Class II2014-10-01

    Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

  • recall — Class II2014-03-26

    Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

  • recall — Class II2014-03-26

    Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

  • recall — Class II2013-05-08

    Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.

  • recall — Class II2012-08-29

    Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

  • recall — Class II2012-08-29

    Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

For suppliers

Is this Noven Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.